chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Unable to bend or move fingers without pain throughout arm and fingers; chills; unable to sleep due to pain; Felt unwell; headaches; Unable to bend or move fingers without pain throughout arm and fingers; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955), via an unspecified route of administration in the left arm on 02Apr2021 at 13:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy. Concomitant medications included ethinylestradiol, norgestimate (SPRINTEC) and cetirizine hydrochloride (ZYRTEC), all for unknown indication from unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 at 09:00, the patient was unable to bend or move fingers without pain throughout arm and fingers along with chills next morning; and only then, about 09:00 to 17:00 (woke up every 30-40 minutes) was unable to sleep due to pain. After felt unwell, headaches, pain throughout arm and underarm when awake. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcomes of unable to bend or move fingers without pain throughout arm and fingers, chills, unable to sleep due to pain, felt unwell and headache were recovering.  No follow-up attempts are needed. No further information is expected.
Reddness at site on right arm, down to midarm. Site swollen, red, hard warm to touch for 2 days. Symptoms decreasing on the third day.
The reading of diabetic reading increased by 20 points; Pink at the injection site; Itchy at injection site; Swelling at injection site; This spontaneous case was reported by a patient and describes the occurrence of BLOOD GLUCOSE INCREASED (The reading of diabetic reading increased by 20 points), VACCINATION SITE ERYTHEMA (Pink at the injection site), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE SWELLING (Swelling at injection site) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Pink at the injection site), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE SWELLING (Swelling at injection site). On 27-Feb-2021, the patient experienced BLOOD GLUCOSE INCREASED (The reading of diabetic reading increased by 20 points). At the time of the report, BLOOD GLUCOSE INCREASED (The reading of diabetic reading increased by 20 points), VACCINATION SITE ERYTHEMA (Pink at the injection site), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE SWELLING (Swelling at injection site) outcome was unknown.            Concomitant product information was not provided.  Treatment information was not provided.
5/2-Pt reports that she still have ongoing sour taste in her mouth and burning tongue sensations, and especially when she consume something spicy the upper part of her mouth hurts. Her lips also have burning sensations. Pt reports she had been seen by her PCP, ENT and Dentist and was prescribed antibiotic, cream for her lips, and even had her the crowning in her mouth changed out and still none of these provide any relief (pt does not have info on the names of the antibiotic or cream prescribed). Pt reports she had even tried mouthwash for dry mouth and still no relief. Pt reports when she drink water the burning feels less, and when she have candy in her mouth it seems to help with the sour taste.  5/5-Patient returned call and is still experiencing burning of the tongue, it has not subsided and has not decreased in sensation. Patient voiced making an appointment with ENT doctor but unsure of when an appointment will be available. She reports once appointment has been made she will follow up with covid hotline.-JD
No additional AE; PROQUAD administered to a 24 year old; This spontaneous information has been received referring to a 24-year-old patient of unknown gender. Information regarding the patient' medical history, concurrent conditions, concomitant therapies and drug allergies or reactions were not provided.   On 04-MAR-2022, at the age of 24 years old, the patient was vaccinated with with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 milliliter, lot #U026799, expiration date: 26-FEB-2023, administered subcutaneously for prophylaxis (product administered to patient of inappropriate age). No additional adverse event was reported.
Patient came in to report an adverse reaction to the flu vaccine she received on 10/11/19.  She said she feels the vaccine was administered too high and it has caused bursitis.  She said there was pain immediately when the shot was put in her arm, but the vaccine was still given.  She said in 1 to 2hours her arm was stiff and painful in a strange way.  She said the pain stopped after a couple of days, but then it returned.  She said she can't sleep on her arm and she has limited range of motion.
Patient was getting stickers after shot, Mom said patient didn't respond to her question then patient reported feeling dizzy. Her body became stiff, eyes rolled back, her arms were stiff, foamy mouth and was unresponsive. She fell to the floor. Mom wasn't able to catch her so she hit her head. Dr. arrived to evaluate and patient came to and was interactive and immediately oriented to where she was but anxious. Fam. history of petit mal seizures. Unclear if episode was syncope/vagal response or seizure, although would be very brief and without postictal  phase if seizure. Full exam normal. Reassurance. F/U visit 6/29/16 diagnosed as syncope after vaccination.
Left upper arm to below elbow warm, swollen and tense. Pt treated with Benadryl.
Headache, body aches, joint pains and low grade fever with feeling warm and fatigue x 36 hours. Headache with severe cervical/thoracic spine/neck pain, fatigue, fogginess has persisted x 10 days. Associated nausea when pain is severe. Sometimes headache is improved; but it usually worsens in the evenings.
Having problems with the breathing; I felt kind of bad; I had a temperature over 100 but it didn''t last long; I was just tired; my arm is still sore, feel like it is going to fall off; I think, I have COPD; Pfizer COVID-19 Vaccine (Booster).; Pfizer COVID-19 Vaccine (Booster).; This is a spontaneous report from a contactable consumer (patient). A 79-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: FE3592), dose 3 via an unspecified route of administration, administered in Arm Left on 08Oct2021 as dose 3 (booster dose), single for covid-19 immunisation (at the age of 79-years-old).  Medical history included diabetes. Concomitant medication included influenza vaccine (FLU VACCINE VII) taken for an unspecified indication from 24Sep2021 to 24Sep2021; atenolol (ATENOLOL) (50 mg); lisinopril (10 mg); furosemide (40mg); glimepiride (4 mg) taken for Diabetes. Historical Vaccine included 1st and 2nd dose of BNT162B2 for COVID-19 immunisation. On 08-oct-2021, the patient experienced pfizer covid-19 vaccine (booster), "i felt kind of bad" on 10Oct2021, i had a temperature over 100 but it didn''t last long on 10Oct2021, i was just tired on 10Oct2021, my arm is still sore, feel like it is going to fall off on 08Oct2021, i think, i have copd on an unspecified date, having problems with the breathing on an unspecified date. The patient underwent lab tests and procedures which included body temperature: over 100 . Therapeutic measures were taken as a result of, i think, i have copd (chronic obstructive pulmonary disease). The patient reported she had never had anything hurt like it is. It must be because it's her right arm, or she was not sure. She was not sure but, she wanted to go to the lung doctor to find that out and going to the lung therapy. Outcome of the event I felt kind of bad and Fever was recovered on an unspecified day in 2021, and that of other events were unknown.   Follow-up attempts are completed. No further information is expected.
No further information provided; HCP reported an inadvertent administration of expired VAQTA.; This spontaneous report was received from a registered nurse regarding a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies, and concomitant therapies were not reported.   On 14-JAN-2021, the patient was inadvertent vaccinated with  an expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) (dose, route of administration, anatomical location and vaccine scheme were not provided lot number S032358 has been verified to be a valid lot number, expiration date was on 11-JAN-20210, as prophylaxis (expired product administered).There was no prior temperature excursions reported. No further information provided. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S032358; expirationdate: 11-JAN-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Felt achy, had low- grade fever, headache prior to going home 08/22/2002. Had right ear pain "for awhile" prior to taking Td vaccine. Symptoms continued until 08/26/2002, saw personal physician that day- reported diagnosed ear infection and sinusitis.
Received rotavirus vaccine 10/26/07 10am.  Developed vomited 13 hours later; by following am vomiting, diarrhea, V only 2 ti, H20y stools x1 wk, profuse diarrhea 3-4 ti/day.  Tolerated PO intake OK, called PCP x2, was told diarrhea not a SE, 2nd call not returned.  Discussed SE of vaccine with pt., discussed risks vs benefits.  Gave vaccine websites & # to CDC.
Suspected vaccination failure; Got the shingles recently; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Got the shingles recently). The outcome of the vaccination failure was unknown and the outcome of the shingles was not resolved.   The reporter considered the vaccination failure and shingles to be possibly related to Shingles vaccine.     The company considered the vaccination failure and shingles to be possibly related to Shingles vaccine.   Additional Information: GSK receipt date: 20-Apr-2023 This case was reported by a patient via interactive digital media. The consumer's sister received the Shingles vaccine and experienced the shingles recently. The follow up would not possible, as no contact, details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The reporter think that the event might have been related to the product or device.
3-15-2003-Jean Vogel,ICP reports that patient noticed red spots on his shoulders, clavicle and scapula while getting out of shower in AM. Spots are approx. 3mm and are resolving at the time of the report at 11AM.
5 days with headache; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced headache. On an unknown date, the outcome of the headache was not recovered/not resolved.   It was unknown if the reporter considered the headache to be related to Shingrix.     Additional Information: Additional Information: GSK Receipt Date: 23-OCT-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient stated that It had been 5 days with headache since he/she got of Shingrix. Additional supportive information: The follow-up would not possible, as no contact, details were available.
pt recv vax & exp aching in legs followed by numbness;pt was unable to stand & was taken to ER;ER MD dx GBS;pt was then seen by neurologist who hosp pt for diagnostic eval & d/c pt;
expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication were not reported. Treatment medications were not reported.
Fever; chills; muscle ache; joint ache; Headache; Injection site pain; This is a spontaneous report received from a contactable other hcp. A 33-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EJ1685; Expiration Date: Mar2021) via an intramuscular route of administration in Arm Right on 12Jan2021 16:00 as single dose for covid-19 immunisation. Medical history included obesity from an unknown date and unknown if ongoing. Concomitant medication(s) included ibuprofen (MOTRIN [IBUPROFEN]) taken for an unspecified indication from 12Jan2021 to 14Jan2021; paracetamol (TYLENOL) taken for an unspecified indication from 12Jan2021 to 14Jan2021. On 12Jan2021 the patient experienced fever, chills, muscle ache, joint ache, headache, injection site pain. The clinical outcome of the event was recovered in 2021. Therapeutic measures were taken as a result of fever, chills, muscle ache, joint ache, headache, injection site pain.  No follow-up attempts are possible. No further information is expected.
The pt experienced a knot with redness one day post vax. The pt also experienced a 3cm area of induration. The pt developed redness to the anterior right thigh. The pt also had a rash behind the neck. Was seen in clinic on 2nd day.
Within 30-45 mins patient reported feeling numbness and tingling of face, injection site swelling, tenderness and pain, woke up to an agonizing headache that made her feel nauseated and laid in bed all day with the ongoing headache/pressure.
states that by evening pt felt lightheaded, nauseated & then vomited; in AM face & eyes were puffy; pt states also on Pred for poison ivy & didn't know if that might be problem;
This spontaneous report as received from a registered nurse refers to a 10 year old male patient with a medical history of unspecified allergic reaction to penicillin in 2006. On an unknown date, the patient was vaccinated subcutaneously with the second dose of VARIVAX (Merck) (dose was not reported, lot # K021485, expiry date 03-NOV-2016). Concomitant medications included CONCERTA and PROZAC. On 07-JUL-2015, after being vaccinated, the patient experienced grand mal seizure. The patient sought medical attention in July 2015, but no treatment was given and no lab diagnostics studies were performed. The patient recovered on 07-JUL-2015. The relatedness between the event of grand mal seizure and VARIVAX (Merck) was not reported. Upon internal review, the event of grand mal seizure was considered to be medically significant. Additional information has been requested.
Pfizer-BioNTech. I suffered from chills, headache, joint and muscle aches, and nausea. The symptoms were severe from 7:30 pm on Monday, the day of the dose (vaccine received at 9:30AM), until 5:30 PM Tuesday (approximately 22 hours). The symptoms were relieved by taking extra strength tylenol every 4 hours. The symptoms were lessened, but still present until 9:30 AM on Wednesday.  I was still suffering from a minor headache all day Thursday. I also had soreness in the injection site, there was no swelling or redness that I noticed; the soreness was mostly gone by Thursday. I have had a left eyelid twitch in the past (randomly), it returned after the vaccine and was very bothersome. Today is Thursday and the eyelid twitch is still bothering me.
Heart rate 104, hoarse with sore throat, some trouble breathing (at times), hot and cold flashes.
Patient experienced minor redness and warmth on her left upper forearm. She reported no pain associated with it. She treated with acetaminophen which helped a bit, but planned on also trying diphenhydramine. She stated there was no progression or spread during the timeline of the reaction, but would consult a physician if it did not improve or if worsened.
11:48pm- vaccine administered 12:03pm- pt reported upper body itching, redness (papular rash on the left side of the neck) O2 Sat 98%, HR 60 pt denies SOA, no edema 12:05pm- Benadryl 12.5mg/5ml @ 10ml po was administered 12:20pm- Pt left, denied SOA, no itching, rash resolved O2 sat 98%
Within a few minutes of receiving vaccine, she reported feeling warm, lightheaded. Exhibited tremulousness. Vitals were checked, bp was 170/101 and HR was 130, O2 sat was 98. She was noted to be taking shallow rapid breaths, however lungs were clear. No rash. Reported chest pain. Due to acharacteristic symptoms for anaphylaxis, hypertension and tachycardia, and history of arrhythmia, we elected not to administer epinephrine. 911 was called and she was transported via EMS to nearby hospital.
Vertigo/patient continues to experience mild vertigo; greater than 35 days between Moderna Covid-19 vaccines; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Apr-2021 and was forwarded to Moderna on 21-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo/patient continues to experience mild vertigo) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 35 days between Moderna Covid-19 vaccines) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 044B2114) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Jul-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 35 days between Moderna Covid-19 vaccines). On an unknown date, the patient experienced VERTIGO (Vertigo/patient continues to experience mild vertigo). At the time of the report, VERTIGO (Vertigo/patient continues to experience mild vertigo) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 35 days between Moderna Covid-19 vaccines) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product information was not provided Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: In follow-up information, reporter contact detail, 2nd dose detail ( vaccination  date, 2nd dose Batch number, Vaccine information), Facility Type were Updated . Event of "Inappropriate schedule of vaccine administered" was added .
Myalgia Narrative:  redness at site, fatigue, loss of smell and taste, brain fog.  Other Relevant History:
Vaccine administered on 8/25/22 has expired on 8/20/22. No adverse outcome. Reporting per guidance of the state. Pt and family notified.
Vertigo began 4/10/21 continues to be an issue. I take benadryl to reduce symptoms but any quick movement, rolling over in bed, turning my head, looking up or down causes severe dizziness and occasional nausea.
Fever next day and large area swelling, erythema, tenderness overlying injection site. Seen in office 2/27 and ER 2/28/2010,? large local reaction vs cellulitis. Continued Augmentin and added SXT and Benadryl.
Extreme soreness, unable to raise arm above elbow level; Extreme headache, wake every 2 hours throughout night. Considerable swelling at injection site.  Heart rate elevated from normal 55-60 to 90+ through at least noon the day following vaccine.  Skin hurts as when a fever is present, though no elevated temperature.
headache, fatigue, chills, muscular body pain, joint pain, low grade temp., nausea. Swelling,pain, redness, warm to touch at injection site Took prescription and over counter medication, in bed all day. Started gradually feeling better the next day
Patient received a 3rd dose of the Pfizer vaccine today.  Long term care facility did not have documentation that patient had received 2nd dose and had patient ready to receive a dose today.  When pharmacy staff returned to store to enter today's vaccination into patient's profile,  it was discovered that patient had already received 2nd dose on Jan 27 2021.  No adverse reaction reported at the time dose was given.
bad sore throat slight head ache fatigue  shortness of breath periodotially  pain at injection spot swelled bruised knot
Fever of 102 F (accompanied by severe headache, pressure) end of March 2021. Then another fever of 101-102 F (accompanied by dry cough) 3 weeks after.
0200/02/26/2021 awakened by being EXTREMELY cold as if laying in snow - nude, Attempted to crawl to bathroom.  Was not strong enough.  Pulled my way up to a standing position and slowly and unsteadily got to bathroom for water,  then to a mountaineering clothes storage closet and put on warmest down trousers and jacket.  Stumbled back into bed and fell immediately asleep.  Slept12 hours during daylight on 02/27/2021  0215/02/27/2021  Awakened by being EXTREMELY HOT and soaked in sweat.  I was wearing normal bed clothes.   Able to walk to bathroom for two glasses of water then returned back to bed, I could not get into bed, falling once even with wife assisting.  Fell immediately asleep once comfortable in bed.  Wife had changed sheet.   It did not occur to us to take my blood pressure (we have a battery operated BP device) nor my temperature.   Upon waking I was just a little weak and able to continue normal activities fully recovered.
Client reported no adverse symptoms but noted that she had been given the wrong shot on 3/30/21 and wanted another Moderna on 4/7/2021.  She was  not revaccinated
Approximately one week post vax, pt experienced deep cramping and pain at injection site, with tingling finger. Physician diagnosed "irritation of muscle." On 12/8/99, improved to dull ache and now has weakness of arm. On 6/21/00, no doctor follow-up. Now aching "off and on".